Cargando…

No impact of performance-based financing on the availability of essential medicines in Burkina Faso: A mixed-methods study

Access to safe, effective, and affordable essential medicines (EM) is critical to quality health services and as such has played a key role in innovative health system strengthening approaches such as Performance-based Financing (PBF). Available literature indicates that PBF can improve EM availabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohmann, Julia, Brenner, Stephan, Koulidiati, Jean-Louis, Somda, Serge M. A., Robyn, Paul Jacob, De Allegri, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021144/
https://www.ncbi.nlm.nih.gov/pubmed/36962391
http://dx.doi.org/10.1371/journal.pgph.0000212
_version_ 1784908411483193344
author Lohmann, Julia
Brenner, Stephan
Koulidiati, Jean-Louis
Somda, Serge M. A.
Robyn, Paul Jacob
De Allegri, Manuela
author_facet Lohmann, Julia
Brenner, Stephan
Koulidiati, Jean-Louis
Somda, Serge M. A.
Robyn, Paul Jacob
De Allegri, Manuela
author_sort Lohmann, Julia
collection PubMed
description Access to safe, effective, and affordable essential medicines (EM) is critical to quality health services and as such has played a key role in innovative health system strengthening approaches such as Performance-based Financing (PBF). Available literature indicates that PBF can improve EM availability, but has not done so consistently in the past. Qualitative explorations of the reasons are yet scarce. We contribute to expanding the literature by estimating the impact of PBF on EM availability and stockout in Burkina Faso and investigating mechanisms of and barriers to change. The study used an explanatory mixed methods design. The quantitative study component followed a quasi-experimental design (difference-in-differences), comparing how EM availability and stockout had changed three years after implementation in 12 PBF and in 12 control districts. Qualitative data was collected from purposely selected policy and implementation stakeholders at all levels of the health system and community, using in-depth interviews and focus group discussions, and explored using deductive coding and thematic analysis. We found no impact of PBF on EM availability and stockouts in the quantitative data. Qualitative narratives converge in that EM supply had increased as a result of PBF, albeit not fully satisfactorily and sustainably so. Reasons include persisting contextual challenges, most importantly a public medicine procurement monopoly; design challenges, specifically a disconnect and disbalance in incentive levels between service provision and service quality indicators; implementation challenges including payment delays, issues around performance verification, and insufficient implementation of activities to strengthen stock management skills; and concurrently implemented policies, most importantly a national user fee exemption for children and pregnant women half way through the impact evaluation period. The case of PBF and EM availability in Burkina Faso illustrates the difficulty of incentivizing and effecting holistic change in EM availability in the presence of strong contextual constraints and powerful concurrent policies.
format Online
Article
Text
id pubmed-10021144
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100211442023-03-17 No impact of performance-based financing on the availability of essential medicines in Burkina Faso: A mixed-methods study Lohmann, Julia Brenner, Stephan Koulidiati, Jean-Louis Somda, Serge M. A. Robyn, Paul Jacob De Allegri, Manuela PLOS Glob Public Health Research Article Access to safe, effective, and affordable essential medicines (EM) is critical to quality health services and as such has played a key role in innovative health system strengthening approaches such as Performance-based Financing (PBF). Available literature indicates that PBF can improve EM availability, but has not done so consistently in the past. Qualitative explorations of the reasons are yet scarce. We contribute to expanding the literature by estimating the impact of PBF on EM availability and stockout in Burkina Faso and investigating mechanisms of and barriers to change. The study used an explanatory mixed methods design. The quantitative study component followed a quasi-experimental design (difference-in-differences), comparing how EM availability and stockout had changed three years after implementation in 12 PBF and in 12 control districts. Qualitative data was collected from purposely selected policy and implementation stakeholders at all levels of the health system and community, using in-depth interviews and focus group discussions, and explored using deductive coding and thematic analysis. We found no impact of PBF on EM availability and stockouts in the quantitative data. Qualitative narratives converge in that EM supply had increased as a result of PBF, albeit not fully satisfactorily and sustainably so. Reasons include persisting contextual challenges, most importantly a public medicine procurement monopoly; design challenges, specifically a disconnect and disbalance in incentive levels between service provision and service quality indicators; implementation challenges including payment delays, issues around performance verification, and insufficient implementation of activities to strengthen stock management skills; and concurrently implemented policies, most importantly a national user fee exemption for children and pregnant women half way through the impact evaluation period. The case of PBF and EM availability in Burkina Faso illustrates the difficulty of incentivizing and effecting holistic change in EM availability in the presence of strong contextual constraints and powerful concurrent policies. Public Library of Science 2022-03-23 /pmc/articles/PMC10021144/ /pubmed/36962391 http://dx.doi.org/10.1371/journal.pgph.0000212 Text en © 2022 Lohmann et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lohmann, Julia
Brenner, Stephan
Koulidiati, Jean-Louis
Somda, Serge M. A.
Robyn, Paul Jacob
De Allegri, Manuela
No impact of performance-based financing on the availability of essential medicines in Burkina Faso: A mixed-methods study
title No impact of performance-based financing on the availability of essential medicines in Burkina Faso: A mixed-methods study
title_full No impact of performance-based financing on the availability of essential medicines in Burkina Faso: A mixed-methods study
title_fullStr No impact of performance-based financing on the availability of essential medicines in Burkina Faso: A mixed-methods study
title_full_unstemmed No impact of performance-based financing on the availability of essential medicines in Burkina Faso: A mixed-methods study
title_short No impact of performance-based financing on the availability of essential medicines in Burkina Faso: A mixed-methods study
title_sort no impact of performance-based financing on the availability of essential medicines in burkina faso: a mixed-methods study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021144/
https://www.ncbi.nlm.nih.gov/pubmed/36962391
http://dx.doi.org/10.1371/journal.pgph.0000212
work_keys_str_mv AT lohmannjulia noimpactofperformancebasedfinancingontheavailabilityofessentialmedicinesinburkinafasoamixedmethodsstudy
AT brennerstephan noimpactofperformancebasedfinancingontheavailabilityofessentialmedicinesinburkinafasoamixedmethodsstudy
AT koulidiatijeanlouis noimpactofperformancebasedfinancingontheavailabilityofessentialmedicinesinburkinafasoamixedmethodsstudy
AT somdasergema noimpactofperformancebasedfinancingontheavailabilityofessentialmedicinesinburkinafasoamixedmethodsstudy
AT robynpauljacob noimpactofperformancebasedfinancingontheavailabilityofessentialmedicinesinburkinafasoamixedmethodsstudy
AT deallegrimanuela noimpactofperformancebasedfinancingontheavailabilityofessentialmedicinesinburkinafasoamixedmethodsstudy